Bismuth-Based Quadruple Therapy with Bismuth Subcitrate, Metronidazole, Tetracycline and Omeprazole in the Eradication of Helicobacter pylori

Bismuth-Based Quadruple Therapy with Bismuth Subcitrate, Metronidazole, Tetracycline and Omeprazole in the Eradication of Helicobacter pylori

BACKGROUND: A previous study showed that 14 days of qid bismuth-based triple therapy with tetracycline 500 mg, metronidazole 250 mg and colloidal bismuth subcitrate 120 mg resulted in excellent Helicobacter pylori eradication rates (89.5%). The present study looked at a shorter treatment period by a...

Full description

Bibliographic Details
Main Authors: Raymond Lahaie, Alain Farley, Chrystian Dallaire, André Archambault, Carlo A Fallone, Terry Ponich, Richard Hunt, Michael Oravec, Paul Whitsitt, Sander Veldhuyzen Van Zanten, Norman Marcon, Robert Bailey, André Dumont, Bich Nguyen, Sylvain Desrochers, Jean Spénard
Format: Article
Language:English
Published: Hindawi Limited 2001-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2001/305756

Internet

http://dx.doi.org/10.1155/2001/305756

Similar Items